and uses for the treatment and diagnosis of ebola virus infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10266584
APP PUB NO 20180016322A1
SERIAL NO

15548883

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for treating and diagnosing Ebola virus disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS 75016
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE CLAUDE BERNARD - LYON 169100 VILLEURBANNE
ENS - ECOLE NORMALE SUPÉRIEURE DE LYON46 ALLEE D'ITALIE LYON 69007

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Reynard, Olivier Lyons, FR 1 0
Volchkov, Viktor Lyons, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00